COVID-19, Flu and RSV
Your guide to FDA-authorized and approved vaccines, tests and treatments for all three illnesses.
Topic Paragraphs
Featured Topics
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Sep 21
TAMA Corporation Issues Allergy Alert for Undeclared Wheat, Soy and Yellow #5 in "Cachapas de Maiz PAISA"
Food & Beverages
Sep 19
Allergen Alert on Undeclared Peanuts in "Cake"
Food & Beverages
Sep 19
Kraft Heinz Issues Voluntary Recall of Select Kraft Singles American Processed Cheese Slices
Food & Beverages
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
FDA’s IT Strategy: Unlocking Potential, Leading Transformation
FDA has released the FDA Information Technology Strategy for Fiscal Years 2024 to 2027 marking a defining roadmap for the agency's technological advancement.
Optimizing Postapproval Safety Studies to Expand Data Generation on Medication Use in Pregnancy
Postapproval pregnancy safety studies can help guide clinical practice and provide useful information for product labeling.
An Update on FDA’s Overdose Prevention Framework - Addressing Critical Areas of Need
An update on activities FDA is taking across the agency in each of the Overdose Prevention Framework priorities.
Recently Published Guidances
Sep 22
Formal Meetings Between the FDA and Sponsors or Applicants of PDUFA Products
Drugs
Sep 22
Alternative Tools: Assessing Drug Manufacturing Facilities Identified in Pending Applications
Drugs
Sep 21
Considerations for the Conduct of Clinical Trials of Medical Products During Major Disruptions Due to Disasters and Public Health Emergencies
Drugs